Good Practices are consensus documents produced by a group of experts – organised in a formal or informal Community of Practice – in order to capture salient aspects of performing a specific activity in the way that the group considers the best possible.
Following the experience accumulated around important documents such as the Good Clinical Practice, the Good Manufacturing Practice, or the Good Laboratory Practice, a group of experts coordinated by the Avicenna Alliance and the VPH Institute is developing the first proposal for Good Simulation Practice (GSP).
Are you an expert on in silico and want to join the conversation on GSP?
Request the access to our Community of Practice
A first step toward the compilation of the GSP is to collect all regulatory documents of the various authorities around the world that are related to this topic.
- ISO 14155, 2020 – Revision of Clinical investigation of medical devices for human subjects — Good clinical practice
- European Commission, 2020 – Guideline. MDCG 2020-1 Guidance on Clinical Evaluation (MDR) / Performance Evaluation (IVDR) of Medical Device Software
- EMA, 2019 – Presentation. Optimise capabilities in modelling, simulation and extrapolation
- IMDRF, 2019 – Guideline. Guidance on Clinical Evaluation (.docx)
- IMDRF, 2019 – Guideline. Clinical Evidence – Key Definitions and Concepts (.docx)
- IMDRF, 2019 – Guideline. Clinical Investigation (.docx)
- FDA, 2019 – Guidance Document. Clinical Decision Support Software
- ASME, 2018 – Technical Standard VV-40 2018 – Assessing Credibility of Computational Modeling through Verification and Validation: Application to Medical Devices
- University of Bath, 2018 – Clinical Trial validation. ToKa HTO Versus Generic HTO Virtual Clinical Trial
- FDA, 2018 – Presentation. How Simulation Can Transform Regulatory Pathways
- FDA, 2018 – Pilot Program. Model-Informed Drug Development Pilot Program
- IMDRF, 2018 – Optimizing Standards for Regulatory Use (.docx)
- EMA, 2017 – Guideline. Reporting of physiologically based pharmacokinetic (PBPK) modelling and simulation.
- IMDRF, 2017 – Software as a Medical Device (SaDM): Clinical Evaluation (.docx)
- EMA, 2016 – Workshop. Workshop on qualification and reporting of physiologically-based pharmacokinetic (PBPK) modelling and simulation
- FDA, 2016 – Guideline. Reporting of Computational Modeling Studies in Medical Device Submissions
- IMDRF, 2014 – “Software as a Medical Device”: Possible Framework for Risk Categorization and Corresponding Considerations (.docx)